Clinical Cancer Research The Science of Cancer Health Disparities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baldus, S. E.
Right arrow Articles by Dienes, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baldus, S. E.
Right arrow Articles by Dienes, H. P.
Clinical Cancer Research Vol. 10, 2790-2796, April 15, 2004
© 2004 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

MUC1 and Nuclear ß-Catenin Are Coexpressed at the Invasion Front of Colorectal Carcinomas and Are Both Correlated with Tumor Prognosis

Stephan E. Baldus1, Stefan P. Mönig2, Sandra Huxel1, Stephanie Landsberg1, Franz-Georg Hanisch3, Katja Engelmann1,3, Paul M. Schneider2, Jürgen Thiele1, Arnulf H. Hölscher2 and Hans P. Dienes1

1 Institute of Pathology, 2 Department of Visceral and Vascular Surgery, and 3 Center of Biochemistry, University of Cologne, Cologne, Germany

Purpose: Overexpression of MUC1 and cytosolic interaction of the mucin with ß-catenin are claimed to be involved in colorectal carcinogenesis. In vitro data published recently suggest that MUC1 overexpression results in an increase of steady state levels of nuclear ß-catenin. We tried to elucidate the coexpression of both molecules in colorectal cancer to demonstrate possible correlations with clinical, pathological, and prognostic data.

Experimental Design: An immunohistochemical double staining study was performed to characterize the expression and subcellular distribution of MUC1 and ß-catenin in a series of 205 patients with colorectal carcinoma. The results were correlated with clinicopathological variables as well as overall survival.

Results: MUC1 was strongly expressed in the tumor center and at the invasion front in ~50% of the cases. Similar results were obtained with regard to nuclear accumulation of ß-catenin at the invasive tumor parts. MUC1 protein expression in the tumor center correlated significantly with a low grade of differentiation, and nuclear ß-catenin in the tumor periphery was more frequent in carcinomas of the left colon and rectum. Overexpression of MUC1 and ß-catenin, as well as their nuclear coexpression at the invasion front correlated with a worse overall survival in an univariate analysis. However, only pathological tumor-node-metastasis staging and MUC1 at the invasion front revealed as independent prognostic factors.

Conclusions: These results suggest that MUC1 and ß-catenin are coexpressed at the invasion front of colorectal carcinomas and that this feature is associated with an accelerated course of disease and worse prognosis.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
A Lugli, I Zlobec, K Baker, P Minoo, L Tornillo, L Terracciano, and J R Jass
Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status
J. Clin. Pathol., May 1, 2007; 60(5): 534 - 539.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
S Uchiyama, H Itoh, S Naganuma, K Nagaike, T Fukushima, H Tanaka, R Hamasuna, K Chijiiwa, and H Kataoka
Enhanced expression of hepatocyte growth factor activator inhibitor type 2-related small peptide at the invasive front of colon cancers
Gut, February 1, 2007; 56(2): 215 - 226.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Kroemer, L. Galluzzi, and C. Brenner
Mitochondrial Membrane Permeabilization in Cell Death
Physiol Rev, January 1, 2007; 87(1): 99 - 163.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Ren, D. Raina, W. Chen, G. Li, L. Huang, and D. Kufe
MUC1 Oncoprotein Functions in Activation of Fibroblast Growth Factor Receptor Signaling
Mol. Cancer Res., November 1, 2006; 4(11): 873 - 883.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Sengupta, J. A. den Boon, I-H. Chen, M. A. Newton, D. B. Dahl, M. Chen, Y.-J. Cheng, W. H. Westra, C.-J. Chen, A. Hildesheim, et al.
Genome-Wide Expression Profiling Reveals EBV-Associated Inhibition of MHC Class I Expression in Nasopharyngeal Carcinoma
Cancer Res., August 15, 2006; 66(16): 7999 - 8006.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Huang, D. Chen, D. Liu, L. Yin, S. Kharbanda, and D. Kufe
MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3{beta}-Mediated Phosphorylation and Degradation of {beta}-Catenin
Cancer Res., November 15, 2005; 65(22): 10413 - 10422.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Levitin, O. Stern, M. Weiss, C. Gil-Henn, R. Ziv, Z. Prokocimer, N. I. Smorodinsky, D. B. Rubinstein, and D. H. Wreschner
The MUC1 SEA Module Is a Self-cleaving Domain
J. Biol. Chem., September 30, 2005; 280(39): 33374 - 33386.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.